osimertinib,tepotinib
merck,AstraZeneca
['osimertinib', 'biomarker', 'marker ']
 we need a little more data first, but i think this is practice changing. significant pt population biomarker drug already in clinical use evidence of clinical activity we have waited so long for an alternative to chemo post osimertinib. here is one answer.
Thoracic medical oncologist | Consultant @ChelwestFT | Vice Chair @BTOGorg | Skier, when snow permits.